Audience Q&A: Best Practices in Managing HER2-Amplified CRC
Fielding questions from the audience, expert oncologists discuss clinical trials, molecular testing, and early-stage disease in the context of HER2-amplified colorectal cancer.
EP: 1.Colorectal Cancer: Prevalence, Workup, and Molecular Subtypes
EP: 2.Colorectal Cancer: An Overview on Molecular Profiling
EP: 3.Role of HER2 Expression in Colorectal Cancer
EP: 4.Role of Circulating Tumor DNA Testing in Colorectal Cancer
EP: 5.Treatment Algorithm for Metastatic Colorectal Cancer
EP: 6.HER2-Amplified Colorectal Cancer: Clinical Trial Data
EP: 7.Real-World Use of HER2-Directed Therapies in Colorectal Cancers
EP: 8.Evolutions in the HER2-Amplified CRC Treatment Landscape
Now Viewing
EP: 9.Audience Q&A: Best Practices in Managing HER2-Amplified CRC
Related Videos
Related Content
